Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke

NCT03763929 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
INDUSTRY
Sponsor class

Stopped The study was stopped due to lack of meaningful enrollment due to the COVID-19 pandemic.

Conditions

Interventions

Sponsor

Diffusion Pharmaceuticals Inc

Collaborators